ライフサイエンスコーパス: microcalcification

1 stortions, and four [67%] of six masses with microcalcifications).

2 oadenoma, or breast cancer (with and without microcalcifications).

3 can distinguish between areas of macro- and microcalcification.

4 to identify pathologically high-risk nascent microcalcification.

5 ysis, (18)F-fluoride selectively highlighted microcalcification.

6 ease of matrix vesicles (MVs), precursors of microcalcification.

7 acrophage-derived MVs contribute directly to microcalcification.

8 The benefits were seen for both masses and microcalcification.

9 redict the risk of malignancy for suspicious microcalcifications.

10 ular-resolution tool to identify preclinical microcalcifications.

11 of small objects that correspond to typical microcalcifications.

12 ), 17 manifested as masses and 12 (41%) were microcalcifications.

13 heterogeneous data set containing masses and microcalcifications.

14 s collected from the cleaning pads resembled microcalcifications.

15 d procedure to remove particles mistaken for microcalcifications.

16 icrocalcifications and recurred as DCIS with microcalcifications.

17 moval of more tissue was helpful with missed microcalcifications.

18 breast, small lesions, small specimens, and microcalcifications.

19 14 (67%) of 21 initially missed lesions, all microcalcifications.

20 ctural distortion, severe neuronal loss, and microcalcifications.

21 Among these, six (54%) had suspicious microcalcifications.

22 masses had multiple associated heterogeneous microcalcifications.

23 ven in the case of a cyst with heterogeneous microcalcifications.

24 distinguish malignant from benign clustered microcalcifications.

25 ost inflammatory reaction with fewer lumenal microcalcifications.

26 was limited to initial identification of the microcalcifications.

27 resh biopsy cores and composition of type II microcalcifications.

28 mammographic findings except pure clustered microcalcifications.

29 rs, 2.1 were masses, and 0.1 were masses and microcalcifications.

30 tion clusters, and 17 of 17 were masses with microcalcifications.

31 ues are available for detecting intratumoral microcalcifications.

32 ng new techniques to predict the presence of microcalcifications.

33 reast cancer, in the absence and presence of microcalcifications.

34 respectively) for diagnosis of lesions with microcalcifications.

35 mosine and isodesmosine cross-linkers in the microcalcifications.

36 ns without, and 0.22 for breast lesions with microcalcifications.

37 e of stereotactic breast needle biopsies for microcalcifications.

38 can be considered for BI-RADS 4 mammographic microcalcifications.

39 gital transition, primarily in patients with microcalcifications.

40 mpt the reader to correctly recall masses or microcalcifications.

41 f 28 masses (nine [32%] malignancies) and 26 microcalcifications (10 [38%] malignancies).

42 ncies, 23 (45%) appeared mammographically as microcalcifications, 12 (24%) as masses, four (8%) as ar

43 es and/or microcalcifications (72 masses, 22 microcalcifications, 17 masses with microcalcifications)

44 Lesion types were masses (66%), microcalcifications (25%), parenchymal deformities (6%),

45 egular mass (56.8% [109 of 192]) followed by microcalcifications (25.0% [48 of 192]).

46 benign and malignant masses and clusters of microcalcifications (3.3-7.4 cm in diameter) were then s

47 ne hundred eleven lesions were masses and/or microcalcifications (72 masses, 22 microcalcifications,

48 [1.09-1.19] vs 1.01 [0.94-1.06]; p=0.0004), microcalcification (73% vs 21%, p=0.002), and necrotic c

49 CAD correctly prompted 100% of microcalcifications, 87% of mass lesions, 80% of asymmet

50 ch assessments, focusing on inflammation and microcalcification activity, the importance of these pro

51 showed displacement of a few of the targeted microcalcifications adjacent to misplaced marker clips.

52 malignant or patients developed four or more microcalcifications after 3 years, biopsy was performed.

53 therapeutic target for ectopic calcification/microcalcification and may clarify the mechanism that un

54 ts without evidence of cancer had testicular microcalcification and one cryptorchidism, risk factors

55 f Raman spectroscopy to concomitantly detect microcalcifications and diagnose associated lesions, inc

56 verall interpretation accuracy, detection of microcalcifications and masses, discrimination between b

57 (DCIS) cases manifested mammographically as microcalcifications and recurred as DCIS with microcalci

58 extracellular vesicles, and the formation of microcalcifications and ultimately large calcification a

59 sses, 22 microcalcifications, 17 masses with microcalcifications) and 21 were architectural distortio

60 diagnosis of breast cancer (with or without microcalcifications) and an overall accuracy of 82.2% fo

61 ding 50 normal tissue sites, 77 lesions with microcalcifications, and 19 lesions without microcalcifi

62 rval decrease in size of lesion or number of microcalcifications, and 4 = no residual mammographic le

63 lity of the structures in the image (fibers, microcalcifications, and masses) was evaluated with the

64 jacent to (n = 6) or associated with (n = 1) microcalcifications, and three (30%) were in or adjacent

65 acent to (n = 12) or associated with (n = 1) microcalcifications, and two (13%) were in masses.

66 on mammograms: four masses, two pleomorphic microcalcifications, and two masses with calcifications.

67 stlumpectomy mammography for cases involving microcalcifications; and calls for flexibility in the ap

68 Microcalcifications appear to derive from matrix vesicle

69 Among the latter group, microcalcifications appeared malignant in four breasts,

70 If microcalcifications appeared malignant or patients devel

71 Microcalcifications are a feature of diagnostic signific

72 guidance of stereotactic breast biopsies for microcalcifications are also discussed.

73 Microcalcifications are an early mammographic sign of br

74 Microcalcifications are an early mammographic sign of br

75 Type I microcalcifications are associated mainly with benign tu

76 Although type II microcalcifications are primarily composed of calcium hy

77 d mainly with benign tumors, whereas type II microcalcifications are produced internally by malignant

78 f lobular neoplasia at core biopsy, residual microcalcifications are viewed in the context of a patie

79 cium carbonate, an underrated constituent of microcalcifications, as a spectroscopic marker in breast

80 erion to rule out malignancy in mammographic microcalcifications at breast MR imaging.

81 d mass and less likely to manifest noncomedo microcalcifications at mammography than were NLCs with n

82 is of malignancy in lesions that manifest as microcalcifications at mammography.

83 ant factor (P < .001) in failure to retrieve microcalcifications at only 11-gauge vacuum biopsy.

84 ast cancer who had densities masquerading as microcalcifications at the resection margins of the lump

85 roscopy decision algorithms to detect breast microcalcifications, based on fit coefficients (FC) deri

86 nsecutively underwent image-guided biopsy of microcalcifications between November 2001 and October 20

87 carboxyfluorescein-alendronate confirmed the microcalcification binding specificity of alendronate de

88 f malignancy in BI-RADS 3 and 5 mammographic microcalcifications, but can be considered for BI-RADS 4

89 model that includes BI-RADS descriptors for microcalcifications can distinguish between benign and m

90 NIR fluorescence tomography of breast cancer microcalcifications can now be compared and optimized.

91 r was used to estimate the likelihood that a microcalcification cluster was due to a malignancy.

92 Overall, 37 of 39 microcalcification clusters (95% sensitivity, 95% confid

93 erpreted by six radiologists who located the microcalcification clusters and rated their conspicuity.

94 mmograms depicting 57 verified masses and 38 microcalcification clusters in 85 positive and 35 negati

95 hile cuing sensitivity affected detection of microcalcification clusters more significantly (P < .01)

96 cm-thick phantoms embedded with 81 simulated microcalcification clusters of three speck sizes (subtle

97 Forty-eight (96.0%) of 50 microcalcification clusters were marked on all three ima

98 erage, 0.5 false-positive rate per view were microcalcification clusters, 2.1 were masses, and 0.1 we

99 lesions detected were masses, 20 of 22 were microcalcification clusters, and 17 of 17 were masses wi

100 four views each), depicting 96 masses and 50 microcalcification clusters, were scanned and analyzed t

101 of breast cancers manifesting as masses and microcalcification clusters, with an acceptable false-po

102 three compression levels for the masses and microcalcification clusters.

103 DBT digital breast tomosynthesis for subtle microcalcification clusters.

104 Thirteen patients (14 breasts) developed microcalcifications confined to the lumpectomy site afte

105 eight patients (29 breasts [5.7%]) developed microcalcifications confined to the lumpectomy site.

106 0.20 for a 6-cm breast phantom, and the mean microcalcification conspicuities were 16.2 +/- 2.87 and

107 For constant glandular dose, mass and microcalcification conspicuity remained approximately co

108 onstructed images were analyzed for mass and microcalcification conspicuity, or the ratio of the lesi

109 carcinoma in situ, infiltrating cancer, and microcalcifications correlated with corresponding histop

110 e image-guided breast biopsies performed for microcalcifications deemed suspicious by radiologists we

111 The microcalcification descriptors and categories in BI-RADS

112 To retrospectively evaluate whether microcalcification descriptors and the categorization of

113 cation descriptors and the categorization of microcalcification descriptors in the Breast Imaging Rep

114 spectroscopy to make predictions for breast microcalcification detection.

115 mmography is an option when benign-appearing microcalcifications develop at the lumpectomy site depen

116 it is the primary recommendation when these microcalcifications develop within 3 years after treatme

117 ant differences among the risks suggested by microcalcification distribution descriptors (P = .004) a

118 esticular microlithiasis is common and while microcalcifications do exist in roughly 50% of germ cell

119 ical mammogram and hybridized with simulated microcalcifications for use in this study.

120 is of these results, we believe that type II microcalcifications formed in benign ducts typically con

121 Microcalcifications geographically target the location o

122 Clinical detection of microcalcifications has been hampered by the lack of ima

123 ging platform that can non-invasively detect microcalcification in active unstable atherosclerosis.

124 d annexin V, which contribute to accelerated microcalcification in chronic renal disease.

125 It has recently been shown that active microcalcification in the coronary arteries, one of the

126 The presence of type II microcalcification in the MDA-MB-231 cell line was confi

127 lso revealed extensive areas of fibrosis and microcalcification in which a predominant smooth muscle

128 sts interpreted mammograms showing clustered microcalcifications in 104 patients.

129 of pixel size on the detection of simulated microcalcifications in a phantom with digital mammograph

130 glial cells and neurons and associated with microcalcifications in all three fatal cases with microc

131 , which are unable to reliably differentiate microcalcifications in benign and malignant breast lesio

132 make accurate and repeatable predictions of microcalcifications in breast tissue using decision algo

133 c and ultrastructural characteristics of the microcalcifications in different mammary tumor types.

134 ive breast cancer--is typically diagnosed as microcalcifications in mammograms.

135 atheromata and participated in formation of microcalcifications in SMC culture.

136 erformed significantly better on masses than microcalcifications in terms of both the area under the

137 tion was found to have new diffuse bilateral microcalcifications in the breast ducts.

138 that minute (10-mum-diameter) cellular-level microcalcifications in the cap, which heretofore have go

139 rotic plaques has suggested that subcellular microcalcifications in the fibrous cap may promote mater

140 ys had scrotal US, 83 (2%) of whom had TM or microcalcifications in the report.

141 rwent stereotactic core biopsy of suspicious microcalcifications in the upper outer left breast with

142 idance, core needle biopsy fails to retrieve microcalcifications in up to 15% of patients.

143 eatures of a lesion such as typical shape of microcalcifications in x-ray mammography, characteristic

144 macrocalcification confers plaque stability, microcalcification is a key feature of high-risk atherom

145 as performed of 1701 consecutive nonpalpable microcalcification lesions in 1511 women aged 29-92 year

146 orphologic parameter, including nodule size, microcalcification, macrocalcification, halo sign, talle

147 tion, clustering, and shape of nearly 35,000 microcalcifications (microCalcs) >/= 5 microm in the fib

148 s developing fewer than four probably benign microcalcifications more than 3 years after treatment we

149 mographic findings other than pure clustered microcalcifications, MR imaging increased the positive p

150 = 16), mass with calcifications (n = 5), and microcalcifications (n = 6; four of these microcalcifica

151 f branching, and associated findings such as microcalcifications, nipple discharge, and interval chan

152 nostic strategy, we were able to distinguish microcalcifications occurring in benign and malignant du

153 scopy to analyze the chemical composition of microcalcifications occurring in benign and malignant le

154 A 53-year-old woman with right breast microcalcifications of intermediate concern underwent st

155 e in the differential diagnosis of clustered microcalcifications on mammograms.

156 ular cancer after previous identification of microcalcifications on ultrasound generated significant

157 gnant lesions manifested mammographically as microcalcifications only, n = 7) were seen better at con

158 associated with interval change, suspicious microcalcifications, or both warrant biopsy.

159 t differences were found for both masses and microcalcification (P = .037 and .049).

160 imarily because of an effect on detection of microcalcifications (P < .01) and discrimination of mass

161 f 144) of masses and 12.5% (148 of 1,182) of microcalcifications (P <.001); and by number of specimen

162 ography outperformed CT for visualization of microcalcifications (P = .006).

163 minations, particularly when associated with microcalcifications (P = .047).

164 Despite their indisputable value, microcalcifications, particularly of the type II variety

165 Microcalcifications play a major role in destabilizing a

166 d multicentric tumors, diffuse indeterminate microcalcifications, pregnancy, prior irradiation to the

167 e deposits originate from an early molecular microcalcification process of 2 types: type 1 is calcium

168 ix leading to the formation of destabilizing microcalcifications remain unclear.

169 (19 [65%] of 29 masses, seven [88%] of eight microcalcifications, seven [78%] of nine architectural d

170 roscopy technique to simultaneously identify microcalcification status and diagnose the underlying br

171 confocal, and electron microscopy to verify microcalcification targeting specificity of DOTA-alendro

172 valuate (64)Cu-DOTA-alendronate as a mammary microcalcification-targeting PET imaging agent, using an

173 masses and less likely to manifest noncomedo microcalcifications than are NLCs with normal E-cadherin

174 lar vesicles participate in the formation of microcalcifications that are implicated in atherosclerot

175 f breast core needle biopsy for detection of microcalcifications that can substantially improve the l

176 ass that changed at 6 months and one case of microcalcifications that changed at 24 months.

177 light subtle chemical differences in type II microcalcifications that correlate with breast disease.

178 se reflectance spectroscopy for detection of microcalcifications that focuses on variations in optica

179 Recent studies have shown that microcalcifications that form within the fibrous cap of

180 ging was used for assessment of mammographic microcalcifications that were assigned Breast Imaging Re

181 For images of microcalcifications, there were significant differences

182 Of 11 lesions with residual microcalcifications, three (27%) were ADH and one (9%) w

183 microcalcifications, and 19 lesions without microcalcifications, using a compact clinical system.

184 for the entire group and for distinguishing microcalcifications versus masses and other findings and

185 The false-negative rate for pure clustered microcalcifications was 12% (three of 25 cases) because

186 sions were gone at follow-up, one cluster of microcalcifications was decreased in size, and one fibro

187 One cluster of microcalcifications was gone at follow-up, and one was s

188 Failure to retrieve microcalcifications was least common with 11-gauge direc

189 s used in this study, while the detection of microcalcifications was significantly reduced with a com

190 existence of the hypothesized cellular-level microcalcifications, we examined autopsy specimens of co

191 fibrosis, glomerular congestion, and tubular microcalcification were all greater with CSA (hazard rat

192 ad undergone biopsy for suspicious clustered microcalcifications were analyzed by a computer.

193 nd microcalcifications (n = 6; four of these microcalcifications were associated with a mammographica

194 The performances of the BP-ANN on masses and microcalcifications were compared with use of receiver o

195 Type I microcalcifications were diagnosed as benign, whereas ty

196 Five lesions with LCIS and residual microcalcifications were excised.

197 In addition, microcalcifications were extracted from a clinical mammo

198 Pure clustered microcalcifications were followed up for at least 24 mon

199 Microcalcifications were initially separated into two ca

200 ght computer-extracted features of clustered microcalcifications were merged by an artificial neural

201 of the specimen were obtained to see whether microcalcifications were retrieved.

202 invasive carcinomas (10 masses, one case of microcalcifications) were detected only mammographically

203 recurrences, 14 (five masses, nine cases of microcalcifications) were detected only mammographically

204 CIS), the most common lesion associated with microcalcifications, which could not be diagnosed using

205 aining that TREML4 colocalizes with areas of microcalcification within coronary plaques.

206 Fifteen patients (15 breasts) developed microcalcifications within 3 years of BCT and were follo

207 eceive BCT, those developing probably benign microcalcifications within 3 years of BCT received close

208 biomechanical modeling indicates that small microcalcifications within the plaque fibrous cap can le

209 e.g. hypoechogenicity, irregular borders and microcalcifications) within such thyroid nodules may hav